Sudeep Pharma Limited (NSE:SUDEEPPHRM)
557.80
-25.45 (-4.36%)
At close: Mar 9, 2026
Sudeep Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2004 | 2003 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '04 Mar 31, 2004 | 2003 |
| Net Income | - | 1,387 | 1,332 | 623.21 | 497.99 | - | Upgrade
|
| Depreciation & Amortization | - | 104.99 | 89.21 | 78.29 | 47.06 | - | Upgrade
|
| Other Amortization | - | 0.92 | 0.92 | 0.89 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.41 | -0.02 | 0.84 | 0.03 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -0.09 | -0.94 | -0.33 | -0.51 | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | 5.96 | -3.04 | 61.55 | 3.23 | - | Upgrade
|
| Other Operating Activities | - | 78 | 17.12 | 50.23 | 19.95 | - | Upgrade
|
| Change in Accounts Receivable | - | -406.57 | -498.91 | 79.02 | -517.42 | - | Upgrade
|
| Change in Inventory | - | -620.88 | 44.15 | -344.62 | -190.67 | - | Upgrade
|
| Change in Accounts Payable | - | 105.85 | 122.24 | 79.88 | 117.35 | - | Upgrade
|
| Change in Other Net Operating Assets | - | -168.61 | -445.99 | -145.01 | -3.4 | - | Upgrade
|
| Operating Cash Flow | - | 487.27 | 656.85 | 483.95 | -26.39 | - | Upgrade
|
| Operating Cash Flow Growth | - | -25.82% | 35.73% | - | - | - | Upgrade
|
| Capital Expenditures | - | -642.33 | -499.86 | -471.53 | -577.54 | - | Upgrade
|
| Sale of Property, Plant & Equipment | - | 3.4 | 0.59 | 0.4 | 0.36 | - | Upgrade
|
| Sale (Purchase) of Real Estate | - | - | -24.76 | - | - | - | Upgrade
|
| Investment in Securities | - | -150 | 30 | -30 | 192.31 | - | Upgrade
|
| Other Investing Activities | - | 1.37 | 1.22 | 0.97 | 0.72 | - | Upgrade
|
| Investing Cash Flow | - | -787.56 | -492.8 | -500.16 | -384.15 | - | Upgrade
|
| Short-Term Debt Issued | - | 296.61 | 9.22 | 33.37 | 384.98 | - | Upgrade
|
| Long-Term Debt Issued | - | 380 | 10 | - | 205.38 | - | Upgrade
|
| Total Debt Issued | - | 676.61 | 19.22 | 33.37 | 590.36 | - | Upgrade
|
| Long-Term Debt Repaid | - | -95.42 | -108.97 | -84.65 | -66.44 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | 581.19 | -89.75 | -51.28 | 523.92 | - | Upgrade
|
| Other Financing Activities | - | -54.23 | -37.6 | -46.49 | -18.2 | - | Upgrade
|
| Financing Cash Flow | - | 526.96 | -127.35 | -97.77 | 505.72 | - | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 1.64 | 0.05 | 2.26 | - | - | Upgrade
|
| Net Cash Flow | - | 228.31 | 36.75 | -111.72 | 95.18 | - | Upgrade
|
| Free Cash Flow | - | -155.06 | 157 | 12.42 | -603.93 | - | Upgrade
|
| Free Cash Flow Growth | - | - | 1164.05% | - | - | - | Upgrade
|
| Free Cash Flow Margin | - | -3.09% | 3.42% | 0.29% | -17.52% | - | Upgrade
|
| Free Cash Flow Per Share | - | -1.43 | 1.45 | 0.11 | -5.57 | - | Upgrade
|
| Cash Interest Paid | - | 54.23 | 37.6 | 46.49 | 18.2 | - | Upgrade
|
| Cash Income Tax Paid | - | 405.5 | 447.47 | 224.2 | 175.44 | - | Upgrade
|
| Levered Free Cash Flow | - | -493.92 | -161.13 | -168.82 | - | - | Upgrade
|
| Unlevered Free Cash Flow | - | -459.8 | -137.26 | -140.18 | - | - | Upgrade
|
| Change in Working Capital | - | -1,090 | -778.51 | -330.73 | -594.14 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.